Improving consumer access to medicines: innovative medicines reclassification in New Zealand (NZ)
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentations + Posters
- By: GAULD, Natalie (University of Auckland, General Practice and Primary Healthcare, Auckland, New Zealand)
- Co-author(s): Kelly, F.J. (University of Auckland, Auckland, New Zealand)
Emmerton, L. (Curtin University, Perth, Australia)
Buetow, S. (University of Auckland, Auckland, New Zealand)
Background: Prescription to non-prescription reclassification has slowed in many developed countries. However, despite a small population and negative pharmaceutical industry environment, reclassification is progressing in NZ, with first-in-world reclassifications of oseltamivir, famciclovir and calcipotriol.Objective: To ascertain why NZ is one.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.